IL17A and systemic lupus erythematosus: In SLE patients and murine models of the disease, there is a significant increase in the CD3+ CD4− CD8− (DN) population of T cells, which normally accounts for less than 5% of the circulating CD3+ T cell population and is a key source of IL-17 [42].